Marta received the degree in Biotechnology at the Francisco de Vitoria University in 2013, where she also obtained the degree "Expert in Methodology and Biotechnology Research". During that time, she performed a four months internship in the University of New York doing her final degree project.
She has a master's degree from the University of Cantabria in Molecular Biology and Biomedicine where she obtained the highest qualification in her final project. She is currently enrolled in the PhD program in Molecular Biology and Biomedicine of Cantabria University, working under the tutelage of Piero Crespo.
Spatial Regulation of Ras-ERK Signals in Cancer
Research lines
-
Spatial regulation of Ras-ERK signals in physiological processes and in cancer
-
Development of antitumoral drugs targeting protein-protein interactions in the Ras-ERK pathway
Funding
-
“Nuevas dianas moleculares en la ruta Ras-ERK: potencial terapéutico en el cáncer de tiroides”. Asociación Española Contra el Cáncer (AECC). GCB141423113. Proyecto coordinado 2014-2019.
-
Red Temática de Investigación Cooperativa sobre el Cáncer (RTICC). RD/12/0036/0033. 2012-2015.
-
“Proteínas Scaffold como moduladores de la resistencia a inhibidores de la ruta RAS-ERK en melanoma”. SAF-2015 63638R. 2016-2018.
-
Grupo incluido en: Centro de Investigación Biomédica en Red sobre el Cáncer (CIBERONC). (CB16/12/00436). 2017-2023.
-
“ERK spatial distribution and dimerization: implications in carcinogenesis”. RTI2018-096658B. 2019-2021.
-
“Repurposing MAPK inhibitors for the treatment of COVID-19”. Proyecto intramural CSIC. CSIC-COV19-095. 2020.
-
Grupo incluido en la Plataforma PTI SALUD GLOBAL-CSIC: SG2103031_2107300020.
-
“Reutilización de inhibidores de MAPK para el tratamiento de COVID-19”. G.CANTABRIA: 2020UIC22-PUB0008.
-
“Proteínas HOX como mediadores de la ruta RAS-ERK”. PID2021-126288OB-I00. 2022-2025. 294.000€. Investigador Principal.
-
“Desarrollo de un marcador de la respuesta terapéutica del melanoma BRAF positivo”. Proyectos de Prueba de Concepto PDC2022-133569-I00. 2023-2025.
